Experts say the treatment could benefit patients with resistant high blood pressure Last updated: May 14, 2026 | 14:38 UAE doctors say the treatment reinforces the UAE’s push for healthcare innovation IANS Dubai: The UAE’s approval of AstraZeneca’s hypertension drug Baxfendy has drawn positive response from doctors, who say the move reflects the country’s growing focus on advanced healthcare, early access to innovative treatments, and personalised patient care. Medical experts have noted that the approval is particularly significant for patients with resistant hypertension, cases where blood pressure remains uncontrolled despite standard medications and lifestyle changes. Hypertension continues to be one of the leading health concerns in the UAE and the wider region, with doctors warning that many patients remain unaware they have the condition until serious complications develop. Get updated faster and for  FREE : Download the  Gulf News  app now - simply  click here .…